Skip to content
Back to meeting Original
Sara Coca Membribes· @scocmem · X·· 2 days agoScore70

ARTEMIS-011

Body

#ESMO26 Presidential Session and concomitant publication in @Annals_Oncology

ARTEMIS-011 Ris-Rez vs gem/doce in prev treated osteosarcoma shows PFS benefit but modest ORR and OS immature

A landmark phase III result opening the door to ADCs in osteosarcoma
@OncoAlert

8 views · 0 likes · 0 reposts · 0 replies

Source: Sara Coca Membribes · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.